山东大学耳鼻喉眼学报 ›› 2021, Vol. 35 ›› Issue (1): 86-91.doi: 10.6040/j.issn.1673-3770.0.2020.157

• • 上一篇    下一篇

降钙素原在甲状腺髓样癌荷瘤鼠血清中的含量及相关性研究

曾博,田兴德   

  1. 长江大学附属第一医院 耳鼻咽喉头颈外科, 湖北 荆州 434000
  • 发布日期:2021-02-01
  • 通讯作者: 田兴德. E-mail:jztian0716@sina.com

Relationship between serum procalcitonin level of tumor-bearing mice and medullary thyroid carcinoma

ZENG Bo, TIAN Xingde   

  1. Department of Otolaryngology & Head and Neck Surgery, the First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei,  China
  • Published:2021-02-01

PDF (PC)

170

摘要： 目的 探讨甲状腺髓样癌血清中降钙素原含量与作为MTC的肿瘤标志物的血清降钙素含量之间的关系。 方法 建立MTC荷瘤小鼠模型,检测小鼠血清中PCT及CT的含量,测量MTC瘤体的瘤质量和体积,分析PCT及CT与MTC肿瘤之间的相关性。 结果 MTC荷瘤小鼠血清中PCT及CT的含量与瘤质量呈显著正相关;MTC荷瘤鼠血清中的PCT与CT含量呈显著正相关。 结论 MTC荷瘤小鼠血清中PCT的含量与CT的含量具有一致性,PCT可以作为MTC的肿瘤标志物。

关键词: 甲状腺髓样癌, 降钙素原, 降钙素, 血清, 含量, 小鼠

Abstract: Objective To study the relationship between serum procalcitonin(PCT)and calcitonin(CT)levels in medullary thyroid carcinoma(MTC). Methods We evaluated the serum PCT and CT levels, tumor weight and volume, and bodyweight using MTC mice models to ascertain the relationship between serum PCT and CT and tumors. Results Serum PCT and CT in the group A mice were significantly and positively correlated with tumor weight; serum PCT and CT were also positively correlated. Conclusions This experiment demonstrates that serum PCT may be used as a tumor marker for MTC, in addition to serum CT, which has demonstrated utility for the diagnosis of MTC.

Key words: Medullary thyroid carcinoma, Procalcitonin, Calcitonin, Serum, Level, Mice

中图分类号: 

  • R762
[1] 陈晓红. 遗传型甲状腺髓样癌的精准化治疗[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 23-27. doi: 10.6040/j.issn.1673-3770.1.2016.07. CHEN Xiaohong. Precision therapy on medullary thyroid carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2016, 30(2): 23-27. doi: 10.6040/j.issn.1673-3770.1.2016.07.
[2] Hadoux J, Pacini F, Tuttle RM, et al. Management of advanced medullary thyroid cancer[J]. Lancet Diabetes Endo, 2016, 4(1): 64-71. doi: 10.1016/S2213-8587(15)00337-X.
[3] 潘新良. 加强甲状腺结节及恶性肿瘤的规范治疗[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 1-11. doi: 10.6040/j.issn.1673-3770.1.2020.037. PAN Xinliang. Improving the standard treatments for thyroid nodules and malignant tumors[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(3): 1-11. doi: 10.6040/j.issn.1673-3770.1.2020.037.
[4] 龚艳萍, 刘枫, 邹秀和, 等. 甲状腺髓样癌的诊治进展[J]. 中国普外基础与临床杂志, 2016, 23(5): 620-625. doi: 10.7507/1007-9424.20160168. GONG Yanping, LIU Feng, ZOU Xiuhe, et al. Progression of diagnosis and treatment of medullary thyroid carcinoma[J]. Chin J Bases Clin General Surg, 2016, 23(5): 620-625. doi: 10.7507/1007-9424.20160168.
[5] Allelein S, Ehlers M, Morneau C, et al. Measurement of basal serum calcitonin for the diagnosis of medullary thyroid cancer[J]. Horm Et Metab, 2018, 50(1): 23-28. doi:10.1055/s-0043-122237.
[6] 陈伟才. 降钙素和癌胚抗原联合检测应用于甲状腺髓样癌诊治的价值[J]. 深圳中西医结合杂志, 2018, 28(7): 19-21. doi: 10.16458/j.cnki.1007-0893.2018.07.008.
[7] Samà MT, Rossetto Giaccherino R, Gallo M, et al. Clinical challenges with calcitonin-negative medullary thyroid carcinoma[J]. J Cancer Res Clin Oncol, 2016, 142(9): 2023-2029. doi:10.1007/s00432-016-2169-5.
[8] Ittner L, Born W, Rau B, et al. Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma[J]. European Journal of Endocrinology, 2002, 147(6): 727-731. doi: 10.1530/eje.0.1470727,
[9] 李逢将, 王凤, 苑鑫, 等. 通过降钙素原异常升高发现甲状腺髓样癌一例[J]. 中华肺部疾病杂志(电子版), 2017, 10(4): 495-496. doi: 10.3877/cma.j.issn.1674-6902.2017.04.033
[10] d'Herbomez M, Caron P, Bauters C, et al. Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking[J]. Eur J Endocrinol, 2007, 157(6): 749-755. doi:10.1530/EJE-07-0566.
[11] Saltiki K, Rentziou G, Stamatelopoulos K, et al. Small medullary thyroid carcinoma: post-operative calcitonin rather than tumour size predicts disease persistence and progression[J]. Eur J Endocrinol, 2014, 171(1): 117-126. doi:10.1530/EJE-14-0076.
[12] Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma[J]. Thyroid, 2015, 25(6): 567-610. doi:10.1089/thy.2014.0335.
[13] Machens A, Dralle H. Biomarker-based risk stratification for previously untreated medullary thyroid cancer[J]. J Clin Endocrinol Metab, 2010, 95(6): 2655-2663. doi:10.1210/jc.2009-2368.
[14] 徐书杭, 李春睿, 刘超. 儿童甲状腺癌的规范化诊治[J]. 山东大学耳鼻喉眼学报, 2017, 31(6): 12-15. doi: 10.6040/j.issn.1673-3770.1.2017.038. XU Shuhang, LI Chunrui, LIU Chao. Optimal management of differentiated thyroid carcinoma in children[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2017, 31(6): 12-15. doi: 10.6040/j.issn.1673-3770.1.2017.038.
[15] 季娟娟, 孙耕耘. 降钙素原和常用炎症指标在脓毒症诊断及预后中的价值[J]. 中华肺部疾病杂志(电子版), 2015, 8(4): 416-420. doi: 10.3877/cma.j.issn.1674-6902.2015.04.002. JI Juanjuan, SUN Gengyun. The diagnostic value and prognostic significance of serum procalcitonin and Common inflammatory markers in patients with sepsis[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2015, 8(4): 416-420. doi: 10.3877/cma.j.issn.1674-6902.2015.04.002.
[16] 高占成. 降钙素原对诊断慢性阻塞性肺疾病急性加重的应用价值[J]. 中华结核和呼吸杂志, 2013, 36(4): 313-314. doi: 10.3760/cma.j.issn.1001-0939.2013.04.025.
[17] 张立, 徐婷, 林勇. 降钙素原指导抗生素治疗策略在社区获得性下呼吸道感染中应用的荟萃分析[J]. 中华结核和呼吸杂志, 2012, 35(4): 275-282. doi: 10.3760/cma.j.issn.1001-0939.2012.04.012. ZHANG Li, XU Ting, LIN Yong. Procalcitonin-guided algorithms of antibiotic therapy in community-acquired lower respiratory tractinfections: a systematic review and meta-analysis of randomized controlled trials[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2012, 35(4): 275-282. doi: 10.3760/cma.j.issn.1001-0939.2012.04.012.
[18] Bihan H, Becker KL, Snider RH, et al. Calcitonin precursor levels in human medullary thyroid carcinoma[J]. Thyroid, 2003, 13(8): 819-822. doi:10.1089/105072503768499716.
[19] Bolko P, Manuszewska-Jopek E, Michaek K, et al. Efficacy of procalcitonin measurement in patients after total thyroidectomy due to medullary thyroid carcinoma[J]. Arch Immunol Ther Exp(Warsz), 2003, 51(6): 415-419.
[20] 赵岚, 崔天盆, 张家衡, 等. 甲状腺髓样癌血清降钙素原异常增高[J]. 中华检验医学杂志, 2015, 38(4): 283-284. doi: 10.3760/cma.j.issn.1009-9158.2015.04.017.
[21] Giovanella L, Imperiali M, Piccardo A, et al. Procalcitonin measurement to screen medullary thyroid carcinoma: a prospective evaluation in a series of 2705 patients with thyroid nodules[J]. Eur J Clin Invest, 2018, 48(6): e12934. doi:10.1111/eci.12934.
[22] 胡欣, 韩雪, 陈国芳, 等. 血清降钙素原在甲状腺髓样癌诊断及随访中的临床价值[J]. 临床内科杂志, 2020, 37(1): 69-70. doi: 10.3969/j.issn.1001-9057.2020.01.023.
[23] Woliński K, Kaznowski J, Klimowicz A, et al. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen[J]. Endokrynol Pol, 2017, 68(4): 434-437. doi:10.5603/EP.a2017.0038.
[24] Trimboli P, Seregni E, Treglia G, et al. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review[J]. Endocr Relat Cancer, 2015, 22(3): R157-R164. doi:10.1530/ERC-15-0156.
[25] Brutsaert EF, Gersten AJ, Tassler AB, et al. Medullary thyroid cancer with undetectable serum calcitonin[J]. J Clin Endocrinol Metab, 2015, 100(2): 337-341. doi:10.1210/jc.2014-3095.
[26] Giovanella L, Verburg FA, Imperiali M, et al. Comparison of serum calcitonin and procalcitonin in detecting medullary thyroid carcinoma among patients with thyroid nodules[J]. Clin Chem Lab Med, 2013, 51(7): 1477-1481. doi:10.1515/cclm-2012-0610.
[1] 程雷,许秋艳,陈浩. 变态反应检测与诊断的临床应用及意义[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 1-6.
[2] 付奕豪,徐逸轩,严宏,张婕. 谷氧还蛋白在眼病中的作用研究进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(3): 125-130.
[3] 李健忠,周永锐,李慧英,李妙编,孙一涤,邱前辉. 彩超引导低温等离子消融术在甲状腺良性结节的临床应用研究[J]. 山东大学耳鼻喉眼学报, 2021, 35(2): 34-38.
[4] 罗露,周恩,欧阳思,陈义,肖旭平,王继华. 42例喉癌患者血清 microRNAlet-7a 水平的变化及意义[J]. 山东大学耳鼻喉眼学报, 2019, 33(5): 96-100.
[5] 王子熹,曲辉,王瑞琦,何海娟,关凯,刘杰,鹿道温. 青岛及北京地区五年间空气中豚草花粉的调查与分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 73-76.
[6] 姜晓丹,董庆喆,党志红,李慎玲,苗玉,赵涵,张念凯. 不同剂量外源性白介素17A干预对变应性鼻炎小鼠气道炎症的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(6): 73-78.
[7] 浦洪波,杜晓东. 无锡地区2 000例变应性鼻炎变应原检测结果分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 105-107.
[8] 邓月,徐亚平,彭浒,陶绮蕾,范静平,孙爱华,吴建. 铁必复颗粒治疗缺铁感音神经性聋患者的疗效分析[J]. 山东大学耳鼻喉眼学报, 2017, 31(1): 75-79.
[9] 金成勋,赵雪,刘悦,魏宁,金春顺. Kimura病11例并文献复习[J]. 山东大学耳鼻喉眼学报, 2016, 30(6): 63-66.
[10] 邰旭辉,杨昕,朱宝玉,曹鋐,褚彦玲,单晓东,姜宇. 辽宁地区2 883例变应性鼻炎患者变应原分布特征[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 39-42.
[11] 余鹏举, 许风雷, 杨军, 陈伟, 江满杰. 血浆1-3-β-D葡聚糖对真菌性鼻窦炎的诊断价值[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 94-97.
[12] 陈晓红. 遗传型甲状腺髓样癌的精准化治疗[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 23-27.
[13] 衡伟伟,后婕,魏先梅,佘万东. TNF-α和IL-8在突发性聋患者血清及外周血单个核细胞中的表达及其意义[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 40-45.
[14] 林莉,杨旭. 白内障术后角膜上皮功能障碍治疗的疗效分析[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 84-86.
[15] 王志远, 张革化. 慢性鼻-鼻窦炎小鼠模型及应用现状[J]. 山东大学耳鼻喉眼学报, 2015, 29(5): 76-78.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 杨长亮,黄治物,姚行齐,诸勇,孙艺 . 正常气骨导听性脑干反应及其应用[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 9 -13 .
[2] 曹忠良 . 颌面复合伤155例临床分析[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 89 -89 .
[3] 毕景云 . 鼻中隔矫正术后血肿的处理[J]. 山东大学耳鼻喉眼学报, 2006, 20(1): 90 -91 .
[4] 刘大昱,潘新良,雷大鹏,许风雷,张立强,栾信庸 . 梨状窝内侧壁癌的手术治疗[J]. 山东大学耳鼻喉眼学报, 2007, 21(1): 8 -11 .
[5] 楼正才 . 掌拳击伤鼓膜损伤机制及临床特点分析[J]. 山东大学耳鼻喉眼学报, 2008, 22(2): 188 -188 .
[6] 刘 艳,刘新义,王金平,李大健 . 后鼓室解剖结构测量观察及临床意义[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 218 -221 .
[7] 赵 敏,王守森,甄泽年,陈贤明,王茂鑫 . 鼻内镜联合显微镜行蝶窦及经蝶鞍区微创手术[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 244 -245 .
[8] 伦 杰,吕心红 . 鼻部脂溢性角化病1例[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 252 -252 .
[9] 王红霞,王鹏程 . NSE、S100及GFAP在视网膜母细胞瘤中的表达及意义[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 263 -264 .
[10] 黄 方,黄海琼,黄建强,何荷蕃 . 支气管内镜视频监视系统在小儿气管-支气管异物诊治中的应用[J]. 山东大学耳鼻喉眼学报, 2008, 22(3): 276 -277 .
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发